Evidence map›Paper›PMID 25892554›Full record

ArticleCell cycle (Georgetown, Tex.)2015

Loss of GM130 in breast cancer cells and its effects on cell migration, invasion and polarity.

Francesco Baschieri, Edith Uetz-von Allmen, Daniel F Legler, Hesso Farhan

Open access · bronzeAbstract read
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. The Role of GM130 in Nervous System Diseases.Frontiers in neurology · 2021
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Francesco Baschieria Biotechnology Institute Thurgau; University of Konstanz ; Kreuzlingen , Switzerland.
Edith Uetz-von Allmen
Daniel F Legler
Hesso Farhan
Biotechnology Institute Thurgau · CHUniversity of Konstanz · DE

Funding

Swiss National Science Foundation 143841
6 · The paper itself

Abstract

Spatially distinct pools of the small GTPase Cdc42 were observed, but the major focus of research so far has been to investigate its signaling at the plasma membrane. We recently showed that the Golgi pool of Cdc42 is relevant for cell polarity and that it is regulated by GM130, a Golgi matrix protein. Loss of GM130 abrogated cell polarity and consistent with the notion that polarity is frequently impaired in cancer, we found that GM130 is downregulated in colorectal cancer. Whether the loss of GM130 solely affects polarity, or whether it affects other processes relevant for tumorigenesis remains unclear. In a panel of breast cancer cells lines, we investigated the consequences of GM130 depletion on traits of relevance for tumor progression, such as survival, proliferation, adhesion, migration and invasion. We show that cellular assays that depend on polarity, such as chemotaxis and wound scratch assays, are only of limited use to investigate the role of polarity modulators in cancer. Depletion of GM130 increases cellular velocity and increases the invasiveness of breast cancer cells, therefore supporting the view that alterations of polarity contribute to tumor progression.

Indexed as

Antibiotics, AntineoplasticApoptosisAutoantigensBreast Neoplasmscdc42 GTP-Binding ProteinCell Line, TumorCell MovementCell PolarityCell ProliferationDoxorubicinFemaleFluorescence Resonance Energy TransferGolgi ApparatusHumansMCF-7 CellsMembrane ProteinsAntibiotics, AntineoplasticAutoantigenscdc42 GTP-Binding ProteinDoxorubicinGolgin subfamily A member 2Membrane ProteinsRNA, MessengerRNA, Small Interfering

Identifiers

PMID25892554
PMCPMC4612654
OpenAlexW1958472476

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.